Product NDC: | 51672-4136 |
Proprietary Name: | Levetiracetam |
Non Proprietary Name: | Levetiracetam |
Active Ingredient(s): | 100 mg/mL & nbsp; Levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51672-4136 |
Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078774 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090210 |
Package NDC: | 51672-4136-9 |
Package Description: | 473 mL in 1 BOTTLE (51672-4136-9) |
NDC Code | 51672-4136-9 |
Proprietary Name | Levetiracetam |
Package Description | 473 mL in 1 BOTTLE (51672-4136-9) |
Product NDC | 51672-4136 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levetiracetam |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 20090210 |
Marketing Category Name | ANDA |
Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
Substance Name | LEVETIRACETAM |
Strength Number | 100 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |